|
|
|
|
| LEADER |
00000cam a2200000 a 4500 |
| 001 |
in00001576254 |
| 005 |
20220616095959.0 |
| 008 |
810401s1981 mdu f000 0 eng d |
| 020 |
|
|
|c $1.50
|
| 035 |
|
|
|a (OCoLC)7321544
|
| 040 |
|
|
|a GPO
|c GPO
|d UtOrBLW
|
| 040 |
|
|
|a GPO
|c GPO
|
| 049 |
|
|
|a EEM1
|
| 074 |
|
|
|a 499-K
|
| 086 |
0 |
|
|a HE 20.4208/2:An 8/10
|
| 099 |
|
|
|a HE 20.4208/2:An 8/10
|
| 245 |
0 |
0 |
|a Guidelines for the clinical evaluation of antiepileptic drugs (adults and children).
|
| 250 |
|
|
|a Revised Jan. 1981.
|
| 260 |
|
|
|a Rockville, Md. :
|b U.S. Department of Health and Human Services, Public Health Service, Food and Drug Administration ;
|a Washington, D.C. :
|b For sale by the Supt. of Docs.,
|c 1981.
|
| 300 |
|
|
|a iii, 9 pages ;
|c 28 cm.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a unmediated
|b n
|2 rdamedia
|
| 338 |
|
|
|a volume
|b nc
|2 rdacarrier
|
| 490 |
1 |
|
|a HHS (FDA) ;
|v 81-3110
|
| 650 |
|
0 |
|a Drugs
|x Testing.
|0 http://id.loc.gov/authorities/subjects/sh85039755
|
| 650 |
|
0 |
|a Anticonvulsants
|x Testing.
|0 http://id.loc.gov/authorities/subjects/sh85005657
|
| 710 |
1 |
|
|a United States.
|b Food and Drug Administration.
|0 http://id.loc.gov/authorities/names/n80126147
|
| 830 |
|
0 |
|a DHHS publication ;
|v no. (FDA) 81-3110.
|0 http://id.loc.gov/authorities/names/n42037386
|
| 907 |
|
|
|y .b26046131
|b 211202
|c 980609
|
| 935 |
|
|
|a BAC6675
|
| 998 |
|
|
|a gd
|b 980604
|c m
|d a
|e -
|f eng
|g mdu
|h 0
|i 4
|
| 999 |
f |
f |
|i 49b34c00-8061-5269-a3c0-cbb55cb3741d
|s 819b2a6e-5a76-534d-9589-631282179e6d
|t 0
|
| 952 |
f |
f |
|p Can Circulate
|a Michigan State University-Library of Michigan
|b Michigan State University
|c MSU Government Documents
|d MSU Government Documents - U.S. Documents, 3 West
|t 0
|e HE 20.4208/2:An 8/10
|h Other scheme
|i Printed Material
|m 31293012172668
|n 1
|
